Skip To Main Content
Jinping Yin on Muck Rack

Jinping Yin

As seen in: Taylor & Francis Online, Dove Medical Press, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jinping

Contact Jinping, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

From Nature to Nanomedicine: Engineered Plant-Derived Nanovesicles for Skin Disease

|
By Jinping Yin, Yanan Li, Zongshi Yue
| Dove Medical Press
Back to Journals » International Journal of Nanomedicine » Volume 21 Authors Yue Z, Yin J, Li Y Received 17 January 2026 Accepted for publication 28 March 2026 Published 7 April 2026 Volume 2026:21 596983 DOI https://doi.org/10.2147/IJN.S596983 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Kamakhya Misra Zongshi Yue,1,* Jinping Yin,2,* Yanan Li1 1Department of Respiration, Children’s Medical Center, The...
Open in Who Shared Issue with article?

Nano-Drug Delivery Systems Targeting MMPs: A Promising Treatment for Gliomas

|
By Jie Liu, Pengfei Xie, Zhicheng Wang, Jinping Yin
| Taylor & Francis Online
Abstract Gliomas are the most prevalent Central Nervous System (CNS) tumors. Among them, glioblastoma (grade IV) is the most challenging brain cancer because of its highly aggressive nature, treatment resistance and poor prognosis. Matrix metalloproteinase (MMP) is a family of zinc-dependent protein hydrolases. In recent years, MMPs have become a research focus owing to their central role in tumor microenvironment remodeling, angiogenesis, invasion, metastasis.
Open in Who Shared View Duplicates (2) Issue with article?

Acquired Resistance to Crizotinib in Advanced Lung Adenocarcinoma with MET Exon 14 Skipping

|
By Yu Zhang, Feng Peng, Jinping Yin
| Lung Cancer Verified
Publication HistoryPublished online: September 15, 2017Accepted: September 10, 2017; Received in revised form: September 3, 2017; Received: August 13, 2017;
Open in Who Shared Issue with article?
See all 4 articles